Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Curr Hepatol Rep. 2015 Jun;14(2):128-138. doi: 10.1007/s11901-015-0261-y.

Authors

Maria E Lozada¹, Roongruedee Chaiteerakij², Lewis R Roberts¹

Affiliations

¹ Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905.
² Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905 and Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand.

No abstract available

Keywords: Bile Duct Cancer; Diagnosis; Early detection; Liver Cancer; Surveillance.

Grants and funding

UL1 TR000135/TR/NCATS NIH HHS/United States